Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 04, 2023

SELL
$13.48 - $18.79 $474,132 - $660,900
-35,173 Reduced 22.8%
119,112 $2.23 Million
Q4 2022

Feb 02, 2023

SELL
$12.61 - $18.74 $11,109 - $16,509
-881 Reduced 0.57%
154,285 $2.13 Million
Q3 2022

Nov 14, 2022

BUY
$15.33 - $20.36 $63,757 - $84,677
4,159 Added 2.75%
155,166 $2.97 Million
Q2 2022

Aug 12, 2022

SELL
$11.63 - $21.55 $724,583 - $1.34 Million
-62,303 Reduced 29.21%
151,007 $2.3 Million
Q1 2022

May 09, 2022

BUY
$16.63 - $27.73 $113,449 - $189,174
6,822 Added 3.3%
213,310 $4.35 Million
Q4 2021

Feb 10, 2022

BUY
$20.7 - $34.18 $276,469 - $456,508
13,356 Added 6.92%
206,488 $6.03 Million
Q3 2021

Nov 09, 2021

SELL
$19.05 - $28.32 $859,231 - $1.28 Million
-45,104 Reduced 18.93%
193,132 $4.17 Million
Q2 2021

Aug 12, 2021

BUY
$18.93 - $25.65 $253,245 - $343,145
13,378 Added 5.95%
238,236 $6.11 Million
Q1 2021

May 12, 2021

SELL
$11.86 - $21.77 $283,501 - $520,390
-23,904 Reduced 9.61%
224,858 $4.1 Million
Q4 2020

Feb 12, 2021

SELL
$7.25 - $11.76 $331,035 - $536,961
-45,660 Reduced 15.51%
248,762 $2.87 Million
Q3 2020

Nov 12, 2020

BUY
$6.53 - $8.6 $64,235 - $84,598
9,837 Added 3.46%
294,422 $2.24 Million
Q2 2020

Aug 04, 2020

SELL
$4.11 - $6.78 $586,755 - $967,933
-142,763 Reduced 33.41%
284,585 $1.87 Million
Q1 2020

May 04, 2020

SELL
$3.15 - $7.39 $71,479 - $167,693
-22,692 Reduced 5.04%
427,348 $2.18 Million
Q4 2019

Feb 10, 2020

BUY
$5.01 - $8.16 $106,161 - $172,910
21,190 Added 4.94%
450,040 $3.45 Million
Q3 2019

Oct 22, 2019

SELL
$5.07 - $7.08 $246,868 - $344,739
-48,692 Reduced 10.2%
428,850 $2.27 Million
Q2 2019

Aug 15, 2019

BUY
$3.43 - $5.6 $989,599 - $1.62 Million
288,513 Added 152.63%
477,542 $2.67 Million
Q1 2019

May 15, 2019

BUY
$3.56 - $4.82 $672,943 - $911,119
189,029 New
189,029 $803,000

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $776M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Essex Investment Management CO LLC Portfolio

Follow Essex Investment Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Essex Investment Management CO LLC with notifications on news.